By jurisdiction
Sport / anti-doping (WADA)
Every compound we track that has a recorded status under Sport / anti-doping (WADA). Tap a name for the full picture, including the U.S. status and primary sources.
| Compound | Status here | Note |
|---|---|---|
| BPC-157 | Restricted | Prohibited at all times under category S0 (non-approved substances). |
| CJC-1295 | Restricted | Prohibited at all times under S2 as a growth-hormone-releasing factor analogue. |
| Ipamorelin | Restricted | Prohibited at all times under S2 as a growth-hormone secretagogue. |
| Melanotan II | Restricted | Prohibited under S2 (peptide hormones). |
| Selank | Restricted | Falls under S0 (non-approved substances); prohibited at all times for tested athletes. |
| Sermorelin | Restricted | GHRH analogs fall under S2; prohibited at all times. |
| TB-500 (Thymosin Beta-4) | Restricted | Prohibited at all times as a growth factor / non-approved substance. |
| GHK-Cu | Unscheduled | Not explicitly named on the Prohibited List. |
| NAD+ | Unscheduled | Not named on the Prohibited List, but IV infusions over 100 mL per 12 hours are prohibited as a method (M2). |
| Semaglutide (compounded) | Unscheduled | Not prohibited; on the WADA Monitoring Program since 2024. |
| Semax | Unscheduled | Not specifically named; a non-approved experimental peptide could fall under the S0 catch-all. |
| Thymosin Alpha-1 | Unscheduled | Not specifically named on the Prohibited List (distinct from thymosin beta-4, which is prohibited). |
| Tirzepatide (compounded) | Unscheduled | Not prohibited; added to the WADA Monitoring Program effective Jan 1, 2026. |